Glycopyrrolate Injection
Product Images NDC 71839-124

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71839-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyco1mlcartoncaplin (Glyco1mlcartoncaplin)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL from BE Pharmaceuticals Inc. Label indicates 25 single-dose vials of 1 mL each. The product is for intramuscular or intravenous administration and contains benzyl alcohol as a preservative. The label notes it is not for use in newborns and provides storage instructions at 20° to 25° C. Manufactured by Caplin Steriles Limited, India.*

FDA Label Image

Glyco1mlvialcaplin (Glyco1mlvialcaplin)

Glycopyrrolate Injection, USP 0.2 mg/mL single dose vial label. The vial contains 1 mL and is for intramuscular or intravenous use. The label indicates the presence of benzyl alcohol and displays manufacturing information by Caplin Steriles Limited, India, and distribution by BE Pharmaceuticals Inc., Cary, NC.*

FDA Label Image

Glyco20mlcartoncaplin (Glyco20mlcartoncaplin)

Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) packaged in a carton for 10 x 20 mL multiple dose vials. Label states for intramuscular or intravenous administration, contains benzyl alcohol, and is not for use in newborns. Manufactured by Caplin Steriles Limited and distributed by BE Pharmaceuticals Inc. The label includes storage instructions and a red notice highlighting newborn use restriction.*

FDA Label Image

Glyco20mlvialcaplin (Glyco20mlvialcaplin)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) in a 20 mL multiple dose vial. The label indicates it is for intramuscular or intravenous use and contains benzyl alcohol. It is labeled as Rx only and not for use in newborns. Manufactured by Caplin Steriles Limited, India, and distributed by BE Pharmaceuticals Inc., Cary, NC.*

FDA Label Image

Glyco2mlcartoncaplin (Glyco2mlcartoncaplin)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) by BE Pharmaceuticals Inc. The label indicates 25 x 2 mL single dose vials, for intramuscular or intravenous administration. It highlights that the product contains benzyl alcohol and is not for use in newborns. Storage instructions specify 20° to 25°C. Distributed by BE Pharmaceuticals Inc., Cary, NC, and manufactured by Caplin Steriles Limited, India.*

FDA Label Image

Glyco2mlvialcaplin (Glyco2mlvialcaplin)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single-dose vial. The label indicates it contains benzyl alcohol and is intended for intramuscular or intravenous use. Manufactured by Caplin Steriles Limited, India, and distributed by BE Pharmaceuticals Inc.*

FDA Label Image

Glyco5mlcartoncaplin (Glyco5mlcartoncaplin)

Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) by BE Pharmaceuticals Inc. The label specifies the drug is for intramuscular or intravenous administration and is supplied as 25 multiple dose vials of 5 mL each. The label includes storage instructions at controlled room temperature (20° to 25°C) and warnings that it contains benzyl alcohol and is not for use in newborns. Manufacturer details include Caplin Steriles Limited, India.*

FDA Label Image

Glyco5mlvialcaplin (Glyco5mlvialcaplin)

Label for glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) multiple dose vial. The label states it contains benzyl alcohol and is for intramuscular or intravenous use, not for use in newborns. The label identifies Caplin Steriles Limited, India as manufacturer and BE Pharmaceuticals Inc., Cary, NC as distributor.*

FDA Label Image

Glycostrcaplin (Glycostrcaplin)

Chemical structure of glycopyrrolate showing its molecular arrangement including a pyrrolidinium ring, ester linkage, and bromide ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.